Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,735,000 | 1,978,000 | 2,122,000 | 3,406,000 | 1,827,000 |
| Marketable Securities | 26,277,000 | 23,991,000 | 21,609,000 | 22,069,000 | 25,886,000 |
| Receivables | 13,380,000 | 14,645,000 | 8,958,000 | 9,843,000 | 9,392,000 |
| Inventories | 8,275,000 | 12,403,000 | 4,381,000 | 5,302,000 | 6,111,000 |
| Other current assets | 11,346,000 | 1,691,000 | 972,000 | 731,000 | 576,000 |
| TOTAL | $61,013,000 | $61,670,000 | $43,076,000 | $46,849,000 | $47,658,000 |
| Non-Current Assets | |||||
| PPE Net | 18,645,000 | 22,780,000 | 13,287,000 | 15,734,000 | 16,632,000 |
| Investments And Advances | 9,747,000 | 13,122,000 | 11,478,000 | 4,856,000 | 3,892,000 |
| Intangibles | 101,483,000 | 110,391,000 | 39,185,000 | 41,880,000 | 45,226,000 |
| Other Non-Current Assets | 4,126,000 | 4,986,000 | 4,122,000 | 5,949,000 | 2,138,000 |
| TOTAL | $134,001,000 | $151,279,000 | $68,072,000 | $68,419,000 | $67,888,000 |
| Total Assets | $195,014,000 | $212,949,000 | $111,148,000 | $115,268,000 | $115,546,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,603,000 | 5,469,000 | 9,320,000 | 5,825,000 | 2,434,000 |
| Accounts payable and accrued liabilities | 3,994,000 | 4,370,000 | 1,751,000 | 2,270,000 | 2,019,000 |
| Accrued Expenses | 2,080,000 | 2,242,000 | 1,667,000 | 1,974,000 | 1,903,000 |
| Other current liabilities | 14,256,000 | 13,583,000 | 11,456,000 | 8,223,000 | 6,512,000 |
| TOTAL | $28,636,000 | $37,225,000 | $27,009,000 | $21,835,000 | $22,099,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 38,410,000 | 43,193,000 | 7,963,000 | 7,314,000 | 5,546,000 |
| Other Non-Current Liabilities | 21,044,000 | 24,238,000 | 15,454,000 | 13,371,000 | 8,528,000 |
| TOTAL | $78,113,000 | $85,278,000 | $26,399,000 | $28,423,000 | $22,089,000 |
| Total Liabilities | $106,749,000 | $122,503,000 | $53,408,000 | $50,258,000 | $44,188,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,995,220 | 8,070,373 | 6,745,270 | 6,760,989 | 7,086,916 |
| Common Shares | 444,000 | 443,000 | 443,000 | 442,000 | 441,000 |
| Retained earnings | 42,716,000 | 40,426,000 | 49,142,000 | 49,660,000 | 49,669,000 |
| Other shareholders' equity | -2,943,000 | 712,000 | -4,737,000 | 1,842,000 | -1,116,000 |
| TOTAL | $88,265,000 | $90,446,000 | $57,740,000 | $65,010,000 | $71,358,000 |
| Total Liabilities And Equity | $195,014,000 | $212,949,000 | $111,148,000 | $115,268,000 | $115,546,000 |